Merrimack Pharmaceuticals, Inc. ( MACK) - Stock Earnings
Stock symbol MACK is outdated, potentially delisted? Maybe it is available on other exchange?
MACK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -391000 USD | — USD |
| 2023Q3 | -279000 USD | — USD |
| 2023Q4 | -240000 USD | — USD |
MACK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -2.5 million USD | 0 USD |
| 2022 | -1.5 million USD | -445000 USD |
| 2023 | -1.2 million USD | — USD |
MACK
Price: $15.14
52 week price:
Earnings Per Share: -0.08 USD
P/E Ratio: -138
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 32078
Ebitda: -5.0 millionMarket Capitalization: 218.4 million